De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is a chronic, progressive, inflammatory and obstructive disease of the intra-and extra-hepatic bile ducts of unknown etiology. Currently, orthotopic liver transplantation (OLT) is the only definitive treatment for PSC-related end-stage liver disease. However, PSC...

Full description

Bibliographic Details
Main Authors: Carmen Landaverde, Vivian Ng, Alisa Sato, James Tabibian, Francisco Durazo, Ronald Busuttil
Format: Article
Language:English
Published: Elsevier 2009-10-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119317545
_version_ 1828144753619763200
author Carmen Landaverde
Vivian Ng
Alisa Sato
James Tabibian
Francisco Durazo
Ronald Busuttil
author_facet Carmen Landaverde
Vivian Ng
Alisa Sato
James Tabibian
Francisco Durazo
Ronald Busuttil
author_sort Carmen Landaverde
collection DOAJ
description Primary sclerosing cholangitis (PSC) is a chronic, progressive, inflammatory and obstructive disease of the intra-and extra-hepatic bile ducts of unknown etiology. Currently, orthotopic liver transplantation (OLT) is the only definitive treatment for PSC-related end-stage liver disease. However, PSC has been known to recur in the grafted liver. Roux-en-Y hepaticojejunostomy is more commonly performed than choledocho-choledochostomy for PSC, although choledochocholedochostomy has been found to be safe and efficacious for PSC if the distal common bile duct is uninvolved at the time of OLT. Our case is unique in that it describes a patient who developed de-novo cholangiocarcinoma in the remnant portion of the native common bile duct six years after OLT with choledochocholedochostomy for PSC-associated end-stage liver disease without having PSC recurrence. In conclusion, our case report indicates that choledochocholedochostomy may not be desirable in PSC due to an increased risk of developing cholangiocarcinoma in the native common bile duct. This risk exists as well with a Roux-en-Y hepaticojejunostomy in the remaining intra-duodenal and intra-pancreatic biliary epithelium, although in theory to a lesser extent. Therefore, the risk of developing cholangiocarcinoma in the recipient common bile duct can only be completely eliminated by performing a Whipple procedure at the time of OLT.
first_indexed 2024-04-11T20:21:44Z
format Article
id doaj.art-886bf518570140e18c2be9475734c52e
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-04-11T20:21:44Z
publishDate 2009-10-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-886bf518570140e18c2be9475734c52e2022-12-22T04:04:48ZengElsevierAnnals of Hepatology1665-26812009-10-0184379383De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitisCarmen Landaverde0Vivian Ng1Alisa Sato2James Tabibian3Francisco Durazo4Ronald Busuttil5University of California, Los Angeles, Department of MedicineUniversity of California, Los Angeles, Department of MedicineUniversity of California, Los Angeles, Department of MedicineUniversity of California, Los Angeles, Department of MedicineUniversity of California, Los Angeles, Department of Medicine; University of California, Los Angeles, Department of Surgery; Correspondence and reprint request:University of California, Los Angeles, Department of SurgeryPrimary sclerosing cholangitis (PSC) is a chronic, progressive, inflammatory and obstructive disease of the intra-and extra-hepatic bile ducts of unknown etiology. Currently, orthotopic liver transplantation (OLT) is the only definitive treatment for PSC-related end-stage liver disease. However, PSC has been known to recur in the grafted liver. Roux-en-Y hepaticojejunostomy is more commonly performed than choledocho-choledochostomy for PSC, although choledochocholedochostomy has been found to be safe and efficacious for PSC if the distal common bile duct is uninvolved at the time of OLT. Our case is unique in that it describes a patient who developed de-novo cholangiocarcinoma in the remnant portion of the native common bile duct six years after OLT with choledochocholedochostomy for PSC-associated end-stage liver disease without having PSC recurrence. In conclusion, our case report indicates that choledochocholedochostomy may not be desirable in PSC due to an increased risk of developing cholangiocarcinoma in the native common bile duct. This risk exists as well with a Roux-en-Y hepaticojejunostomy in the remaining intra-duodenal and intra-pancreatic biliary epithelium, although in theory to a lesser extent. Therefore, the risk of developing cholangiocarcinoma in the recipient common bile duct can only be completely eliminated by performing a Whipple procedure at the time of OLT.http://www.sciencedirect.com/science/article/pii/S1665268119317545Primary sclerosing cholangitisOrthotopic liver transplantationCholedochocholedochostomy
spellingShingle Carmen Landaverde
Vivian Ng
Alisa Sato
James Tabibian
Francisco Durazo
Ronald Busuttil
De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
Annals of Hepatology
Primary sclerosing cholangitis
Orthotopic liver transplantation
Choledochocholedochostomy
title De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
title_full De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
title_fullStr De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
title_full_unstemmed De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
title_short De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
title_sort de novo cholangiocarcinoma in native common bile duct remnant following olt for primary sclerosing cholangitis
topic Primary sclerosing cholangitis
Orthotopic liver transplantation
Choledochocholedochostomy
url http://www.sciencedirect.com/science/article/pii/S1665268119317545
work_keys_str_mv AT carmenlandaverde denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis
AT vivianng denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis
AT alisasato denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis
AT jamestabibian denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis
AT franciscodurazo denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis
AT ronaldbusuttil denovocholangiocarcinomainnativecommonbileductremnantfollowingoltforprimarysclerosingcholangitis